Access peer-reviewed publications, clinical validation studies, regulatory documents, and technical specifications
Comprehensive study on the temporal profiles of GFAP and UCH-L1 in patients with traumatic brain injury, published in JAMA Neurology.
View on JAMA NetworkMulticenter validation study demonstrating the clinical utility of GFAP and UCH-L1 for detecting traumatic brain injuries.
View in The Lancet NeurologyClinical validation of the Banyan Brain Trauma Indicator, the first FDA-cleared blood test for evaluating mild traumatic brain injury.
View Full StudyProspective study comparing the diagnostic accuracy of GFAP and S100β in detecting traumatic intracranial lesions on CT scans.
View in Clinical ChemistryComplete regulatory submission package for CDSCO approval, including device classification, safety data, and manufacturing standards.
Certification demonstrating compliance with international quality standards for medical device design and manufacturing.
Comprehensive technical documentation including device specifications, performance characteristics, and integration guidelines.
Technical white paper explaining the underlying technology, sensor design, and biomarker detection methodology.
Comprehensive market analysis covering TAM, competitive landscape, and growth projections for point-of-care TBI diagnostics in India.
Analysis of potential social and economic impact of widespread TBI detection deployment in underserved communities.